Kayser V, Besson J M, Guilbaud G
Unité de Recherche de Physiopharmacologie du Système Nerveux, I.N.S.E.R.M., U 161, Paris, France.
Eur J Pharmacol. 1991 Mar 19;195(1):37-45. doi: 10.1016/0014-2999(91)90379-5.
The effects of the analgesic agent tramadol (0.1-1 mg/kg i.v.) were compared to those of the mixed agonist-antagonist analgesics nalbuphine (1 mg/kg i.v.) and buprenorphine (3 micrograms/kg i.v.) in the vocalization threshold to paw pressure test. Normal and Freund's adjuvant-induced arthritic rats were used. We have shown previously that these animals used as a model of clinical pain exhibit an enhanced sensitivity to morphine (0.1-1 mg/kg i.v.), with a rapid development of tolerance after repetitive low doses, a response not observed in normal rats. In the present study, the antinociceptive effects of tramadol, buprenorphine and nalbuphine were enhanced (by 2- to 5-fold) in arthritic compared to normal rats. In this model, these effects were significantly reduced by a dose of naloxone (0.1 mg/kg i.v.) that completely antagonized the effect of morphine. In this model, the antinociceptive effect of tramadol (1 mg/kg i.v.) was comparable to that of nalbuphine (1 mg/kg i.v.), buprenorphine (3 micrograms/kg i.v.) and morphine (1 mg/kg i.v.). Repeated administration of low doses of tramadol twice daily for 4 days to arthritic rats did not induce tolerance, in contrast to nalbuphine, buprenorphine, and morphine. In addition, no cross-tolerance between tramadol and morphine was observed in these animals.
在爪部压力发声阈值测试中,将镇痛剂曲马多(静脉注射0.1 - 1毫克/千克)的效果与混合激动剂-拮抗剂镇痛药纳布啡(静脉注射1毫克/千克)和丁丙诺啡(静脉注射3微克/千克)的效果进行了比较。使用了正常大鼠和弗氏佐剂诱导的关节炎大鼠。我们之前已经表明,这些用作临床疼痛模型的动物对吗啡(静脉注射0.1 - 1毫克/千克)表现出增强的敏感性,在重复低剂量给药后会迅速产生耐受性,而正常大鼠中未观察到这种反应。在本研究中,与正常大鼠相比,曲马多、丁丙诺啡和纳布啡在关节炎大鼠中的抗伤害感受作用增强了(2至5倍)。在这个模型中,一剂纳洛酮(静脉注射0.1毫克/千克)显著降低了这些作用,该剂量完全拮抗了吗啡的作用。在这个模型中,曲马多(静脉注射1毫克/千克)的抗伤害感受作用与纳布啡(静脉注射1毫克/千克)、丁丙诺啡(静脉注射3微克/千克)和吗啡(静脉注射1毫克/千克)相当。与纳布啡、丁丙诺啡和吗啡不同,对关节炎大鼠每天两次重复给予低剂量曲马多,持续4天,并未诱导出耐受性。此外,在这些动物中未观察到曲马多和吗啡之间的交叉耐受性。